Bronchoscopy and bleeding risk

Eur Respir Rev. 2017 Jul 19;26(145):170052. doi: 10.1183/16000617.0052-2017. Print 2017 Sep 30.

Author

Felix J F Herth¹

Affiliation

¹ Dept of Pneumology and Critical Care Medicine, Thoraxklinik Heidelberg at Heidelberg University and Translational Lung Research Center (TLRC), member of the German Center for Lung Research, Heidelberg, Germany felix.herth@med.uni-heidelberg.de.

Abstract

Two new reviews of antithrombotic agents give recommendations regarding use in bronchoscopy patients http://ow.ly/2c7q30cObBt

Publication types

Editorial
Introductory Journal Article

MeSH terms

Age Factors
Anticoagulants / adverse effects
Bronchoscopy / adverse effects*
Comorbidity
Fibrinolytic Agents / adverse effects
Hematologic Agents / adverse effects*
Hemorrhage / chemically induced
Hemorrhage / etiology*
Humans
Platelet Aggregation Inhibitors / adverse effects
Risk Assessment
Risk Factors

Substances

Anticoagulants
Fibrinolytic Agents
Hematologic Agents
Platelet Aggregation Inhibitors